AIEC colonization and pathogenicity: influence of previous antibiotic treatment and preexisting inflammation - PubMed (original) (raw)
Comparative Study
. 2012 Oct;18(10):1923-31.
doi: 10.1002/ibd.22908. Epub 2012 Feb 16.
Affiliations
- PMID: 22344932
- DOI: 10.1002/ibd.22908
Comparative Study
AIEC colonization and pathogenicity: influence of previous antibiotic treatment and preexisting inflammation
Maryline Drouet et al. Inflamm Bowel Dis. 2012 Oct.
Abstract
Background: Inflammatory bowel diseases (IBD) patients are abnormally colonized by adherent-invasive Escherichia coli (AIEC). NOD2 gene mutations impair intracellular bacterial clearance. We evaluated the impact of antibiotic treatment on AIEC colonization in wildtype (WT) and NOD2 knockout mice (NOD2KO) and the consequences on intestinal inflammation.
Methods: After 3 days of antibiotic treatment, mice were infected for 2 days with 10⁹ CFU AIEC and sacrificed 1, 5, and 60 days later. In parallel, mice were challenged with AIEC subsequent to a dextran sodium sulfate (DSS) treatment and sacrificed 9 days later. Ileum, colon, and mesenteric tissues were sampled for AIEC quantification and evaluation of inflammation.
Results: Without antibiotic treatment, AIEC was not able to colonize WT and NOD2KO mice. Compared with nontreated animals, antibiotic treatment led to a significant increase in ileal and colonic colonization of AIEC in WT and/or NOD2KO mice. Persistent AIEC colonization was observed until day 5 only in NOD2KO mice, disappearing at day 60. Mesenteric translocation of AIEC was observed only in NOD2KO mice. No inflammation was observed in WT and NOD2KO mice treated with antibiotics and infected with AIEC. During DSS-induced colitis, colonization and persistence of AIEC was observed in the colon. Moreover, a dramatic increase in clinical, histological, and molecular parameters of colitis was observed in mice infected with AIEC but not with a commensal E. coli strain.
Conclusions: Antibiotic treatment was necessary for AIEC colonization of the gut and mesenteric tissues and persistence of AIEC was dependent on NOD2. AIEC exacerbated a preexisting DSS-induced colitis in WT mice.
Copyright © 2012 Crohn's & Colitis Foundation of America, Inc.
Similar articles
- Escherichia coli in chronic inflammatory bowel diseases: An update on adherent invasive Escherichia coli pathogenicity.
Martinez-Medina M, Garcia-Gil LJ. Martinez-Medina M, et al. World J Gastrointest Pathophysiol. 2014 Aug 15;5(3):213-27. doi: 10.4291/wjgp.v5.i3.213. World J Gastrointest Pathophysiol. 2014. PMID: 25133024 Free PMC article. Review. - Vitamin D deficiency predisposes to adherent-invasive Escherichia coli-induced barrier dysfunction and experimental colonic injury.
Assa A, Vong L, Pinnell LJ, Rautava J, Avitzur N, Johnson-Henry KC, Sherman PM. Assa A, et al. Inflamm Bowel Dis. 2015 Feb;21(2):297-306. doi: 10.1097/MIB.0000000000000282. Inflamm Bowel Dis. 2015. PMID: 25590952 - IL-17 is a protection effector against the adherent-invasive Escherichia coli in murine colitis.
Zhang HJ, Xu B, Wang H, Xu B, Wang GD, Jiang MZ, Lei C, Ding ML, Yu PF, Nie YZ, Wu KC, Sha SM, Li MB. Zhang HJ, et al. Mol Immunol. 2018 Jan;93:166-172. doi: 10.1016/j.molimm.2017.11.020. Epub 2017 Nov 28. Mol Immunol. 2018. PMID: 29195141 - Siderophore Immunization Restricted Colonization of Adherent-Invasive Escherichia coli and Ameliorated Experimental Colitis.
Gerner RR, Hossain S, Sargun A, Siada K, Norton GJ, Zheng T, Neumann W, Nuccio SP, Nolan EM, Raffatellu M. Gerner RR, et al. mBio. 2022 Oct 26;13(5):e0218422. doi: 10.1128/mbio.02184-22. Epub 2022 Sep 12. mBio. 2022. PMID: 36094114 Free PMC article. - Adherent-invasive Escherichia coli in inflammatory bowel disease.
Rolhion N, Darfeuille-Michaud A. Rolhion N, et al. Inflamm Bowel Dis. 2007 Oct;13(10):1277-83. doi: 10.1002/ibd.20176. Inflamm Bowel Dis. 2007. PMID: 17476674 Review.
Cited by
- Delivery of a mucin domain enriched in cysteine residues strengthens the intestinal mucous barrier.
Gouyer V, Dubuquoy L, Robbe-Masselot C, Neut C, Singer E, Plet S, Geboes K, Desreumaux P, Gottrand F, Desseyn JL. Gouyer V, et al. Sci Rep. 2015 May 14;5:9577. doi: 10.1038/srep09577. Sci Rep. 2015. PMID: 25974250 Free PMC article. - Escherichia coli in chronic inflammatory bowel diseases: An update on adherent invasive Escherichia coli pathogenicity.
Martinez-Medina M, Garcia-Gil LJ. Martinez-Medina M, et al. World J Gastrointest Pathophysiol. 2014 Aug 15;5(3):213-27. doi: 10.4291/wjgp.v5.i3.213. World J Gastrointest Pathophysiol. 2014. PMID: 25133024 Free PMC article. Review. - Acute Infectious Gastroenteritis Potentiates a Crohn's Disease Pathobiont to Fuel Ongoing Inflammation in the Post-Infectious Period.
Small CL, Xing L, McPhee JB, Law HT, Coombes BK. Small CL, et al. PLoS Pathog. 2016 Oct 6;12(10):e1005907. doi: 10.1371/journal.ppat.1005907. eCollection 2016 Oct. PLoS Pathog. 2016. PMID: 27711220 Free PMC article. - The Role of Enterobacteriaceae in Gut Microbiota Dysbiosis in Inflammatory Bowel Diseases.
Baldelli V, Scaldaferri F, Putignani L, Del Chierico F. Baldelli V, et al. Microorganisms. 2021 Mar 27;9(4):697. doi: 10.3390/microorganisms9040697. Microorganisms. 2021. PMID: 33801755 Free PMC article. Review. - Growth Control of Adherent-Invasive Escherichia coli (AIEC) by the Predator Bacteria Bdellovibrio bacteriovorus: A New Therapeutic Approach for Crohn's Disease Patients.
Bonfiglio G, Neroni B, Radocchia G, Pompilio A, Mura F, Trancassini M, Di Bonaventura G, Pantanella F, Schippa S. Bonfiglio G, et al. Microorganisms. 2019 Dec 20;8(1):17. doi: 10.3390/microorganisms8010017. Microorganisms. 2019. PMID: 31861852 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical